1. Introduction {#sec1}
===============

High levels of chronic sedentary behaviour are associated with increased risk of obesity \[[@B1], [@B2]\], diabetes \[[@B1], [@B3]\], cardiovascular disease \[[@B4]--[@B6]\], some cancers \[[@B7]\], and even mortality \[[@B3]--[@B5]\]. For example, it has been reported that sedentary behaviour is prospectively associated with increased risk of all-cause and cardiovascular disease mortality, and that these associations remain significant after control for physical activity, diet, and smoking \[[@B4]\]. These findings suggest that sedentary behaviour should not be viewed as simply the lack of physical activity but may instead represent an independent and distinct risk factor for chronic disease.

In addition to the health impact of chronic sedentary behaviour, recent evidence suggests that increases in metabolic risk may be apparent following bouts of uninterrupted sedentary behaviour lasting just a few days in length \[[@B8]--[@B11]\]. Stephens et al. reported that a single day of uninterrupted sitting resulted in a 39% reduction in whole body insulin action in healthy adults \[[@B11]\]. Similarly, Hamburg et al. observed that 5 days of continuous bed rest produced deleterious changes in cholesterol, triglyceride, glucose, and insulin levels and reduced insulin sensitivity \[[@B10]\]. These findings are supported by work in animal models, which suggest that just 6--24 hours of sedentary behaviour results in significant reductions in lipoprotein lipase activity \[[@B12]\] and insulin sensitivity \[[@B13], [@B14]\] in skeletal muscle.

Although several narrative reviews have discussed the acute changes in metabolic risk following short-term exposure to uninterrupted sedentary behaviour \[[@B8], [@B9], [@B15], [@B16]\], the published literature in this area has yet to be examined systematically. Therefore, we conducted a systematic review examining the impact of uninterrupted sedentary behaviour lasting ≤7 days (operationally defined as an "acute" bout) on insulin sensitivity, glucose tolerance, and lipid, glucose, and insulin levels in humans.

2. Methods {#sec2}
==========

2.1. Study Criteria {#sec2.1}
-------------------

To be included in this paper, a study had to examine at least one of the following risk markers in humans: insulin sensitivity, glucose tolerance, or fasting insulin, glucose, or lipid levels. Uninterrupted sedentary behaviour had to be imposed by the researchers for a period lasting 7 days or less. Studies examining longer (e.g., chronic) bouts of sedentary behaviour were excluded as it was felt that it would be inappropriate to consider the impacts of both acute and chronic sedentary behaviour in a single systematic review, given the large amount of heterogeneity that this would introduce into the methodologies of included studies. Only intervention studies (both randomized and nonrandomized) that imposed on participants a controlled bout of sedentary behaviour were included in this paper.

For the purposes of this paper, sedentary behaviour was defined as a distinct class of waking behaviours characterized by little physical movement and low-energy expenditure (≤1.5 METs), as well as a sitting or reclining posture \[[@B9]\]. Eligible forms of sedentary behaviour included sitting, bed rest (head-up, horizontal, and head-down), and casting (e.g., having one or more legs immobilized in a cast). There were no restrictions placed on the age or sex of participants. Only articles published in English or French were included in the present review, and no limits were placed on the date of publication. The review methodology was prospectively registered in PROSPERO (Registration number: CRD42011001431).

2.2. Search Strategy {#sec2.2}
--------------------

Literature searches were performed using Ovid Medline and Ovid Embase in March of 2012. The search strategy was created with the help of a research librarian and run by TJS (see [Algorithm 1](#alg1){ref-type="fig"}). Potentially relevant articles were also identified by 6 key informants and through the authors\' personal reference libraries. Articles were extracted as text files from the Ovid interface and imported into Reference Manager (Thompson Reuters, San Fransisco, CA, USA). Duplicate articles were first removed using the Ovid interface, and any remaining duplicates were removed manually. Once imported into Reference Manager, conference abstracts were also removed from the database.

Titles and abstracts of articles identified through the search were reviewed by two authors (T. J. Saunders and R. Larouche) using Reference Manager. Any articles identified as being potentially relevant by either reviewer were obtained for further screening. The full text of these articles was then reviewed independently by TJS and RL to determine whether the article met the *a priori*review inclusion criteria. All decisions at this stage were made by consensus and any discrepancies between the two reviewers were resolved through discussion. In this paper consensus was reached for all included articles.

2.3. Data Extraction and Analysis {#sec2.3}
---------------------------------

Data was extracted by T. J. Saunders and verified by R. Larouche. Information was extracted regarding study design (year, methodology, country, number of participants, duration of sedentary behaviour, age), modality of sedentary behaviour, risk factors examined, and main findings. Reviewers were not blinded to the authors or journals when extracting data. The primary summary measure was the mean difference in each outcome measure (or mean change in nonrandomized interventions) following exposure to acute sedentary behaviour. Where possible, effect sizes were calculated using Cohen\'s *d*. We defined an effect size of ≤0.20 as small, an effect of 0.21--0.80 as moderate, and effects ≥0.81 as large. For the purposes of this paper, positive effect sizes represent increased cardiometabolic risk (e.g., increased fasting triglyceride levels), while negative effect sizes represent reduced risk.

Following data extraction it became clear that the interventions included in the present paper were very heterogeneous in terms of the length of exposure, the type of sedentary behaviour that was examined, and even the measurement of individual risk factors (e.g., insulin sensitivity was assessed using HOMA, QUICKI, whole body insulin action, oral glucose tolerance tests, and hyperinsulinemic clamps). Thus, we believe that meta-analyses or pooling of data across studies would be inappropriate and have therefore performed a qualitative synthesis of the evidence instead.

Forest plots were created using Review Manager 5.1 (The Nordic Cochrane Centre, The Cochrane Collaboration) to display the relationship between sedentary behaviour and each outcome of interest. Studies assessing glucose tolerance and insulin sensitivity employed a wide range of methodologies and units of measurement, and plots for these outcomes are therefore presented as percent mean difference, while all other outcomes are presented as mean difference with 95% confidence interval. Studies which did not provide raw data were not included in forest plots.

2.4. Quality of Evidence {#sec2.4}
------------------------

The risk of bias and strength of evidence from individual studies was assessed using the Downs and Black Checklist \[[@B17]\]. This 27 point checklist assesses the strength of reporting, external validity, internal validity, and power. As some questions are worth more than one point, the maximum score that a study can receive is 32.

The quality of evidence for each outcome was assessed as high, moderate, low, or very low using the GRADE approach \[[@B18]\]. In this approach, randomized trials begin as high-quality evidence and observational studies begin as low-quality evidence. For the purposes of this paper, nonrandomized interventions were considered as observational studies. Following the initial rating based on study design, the quality of evidence was then rated up or down for apparent risk of bias, imprecision, inconsistency, indirectness, or suspicion of publication bias. Risk of bias was assessed using Review Manager Version 5.1 (The Nordic Cochrane Centre, The Cochrane Collaboration), and GRADE was assessed using GRADEpro Version 3.6 (GRADE Working Group).

3. Results {#sec3}
==========

3.1. Description of Studies {#sec3.1}
---------------------------

After deduplication and the removal of conference abstracts the search strategy retrieved 5,670 articles for initial screening ([Figure 1](#fig1){ref-type="fig"}). To this, 16 additional articles that were identified through key informants were added, bringing the total number of potential articles to 5,686. Initial screening of titles and abstracts identified 85 articles that received a detailed assessment of the full text article. Reasons for excluding studies included an ineligible exposure (e.g., the bout of sedentary behaviour exceeded 7 days, or simply investigated the impact of reducing structured physical activity in active individuals, without actually imposing sedentary behaviour) (*n* = 26), the article being written in a language other than English or French (*n* = 12), ineligible outcome (*n* = 7), the article being a review or commentary (*n* = 10), and "other" (*n* = 2). Some articles were excluded for multiple reasons.

A total of 29 articles reporting data from 25 independent interventions met all inclusion criteria and are presented in the current review. Nineteen of the identified interventions were nonrandomized trials, 4 were randomized crossover studies (e.g., participants served as their own controls), and 2 were randomized controlled trials. The studies included a total of 368 participants (309 males and 59 females), who were recruited from 12 countries across North America (USA), Europe (Denmark, France, Bulgaria, Russia, Greece, Sweden, Poland, and Slovakia, Norway), Asia (Japan), and Oceania (Australia). Participants ranged from 18 to 72 years of age, although the average age of participants was under 35 years for all but 3 studies, and under 30 for all but 7 studies. Sixteen studies employed head-up or horizontal bed rest, 5 employed head-down bed rest, 4 employed sitting, and one employed casting (one employed both sitting and head-down bed rest). The smallest studies had 5 participants \[[@B19], [@B20]\] and the largest had 38 \[[@B21]\]. The mean number of participants per study was 15.1 ± 10.1, and the median was 10.

Three studies examined the impact of 2, 4, and 5 hours of uninterrupted sedentary behaviour on biomarkers of interest, respectively; all other studies examined the impact of 1 day or more. Six studies examined the impact of 1 day of sedentary behaviour, 4 examined 2 days, 7 examined 3 days, 2 examined 4 days, 6 examined 5 days, 2 examined 6 days, and 8 examined the impact of 7 days of sedentary behaviour (6 studies collected data at multiple time-points). Characteristics of individual studies are presented in [Table 1](#tab1){ref-type="table"}.

3.2. Fasting Insulin {#sec3.2}
--------------------

Two randomized crossover studies (*n* = 22) \[[@B11], [@B22]\] and 12 nonrandomized intervention studies (*n* = 185) \[[@B10], [@B21], [@B23]--[@B32]\] examined the impact of sedentary behaviour on fasting insulin levels ([Figure 2](#fig2){ref-type="fig"}). Neither randomized crossover study observed significant changes in insulin levels as a result of uninterrupted sedentary behaviour, despite having effect sizes in the moderate range. Stephens et al. \[[@B11]\] reported that fasting insulin levels were 47.6 ± 11.6 pmol/L following one full day (17 hours) of uninterrupted sitting, compared to 39.3 ± 16.3 pmol/L following a day that included as little sitting as possible (\~6 hours of sitting spread throughout the day) in a group of 12 healthy young adults. Duran-Valdez et al. \[[@B22]\] also observed nonsignificant increases following 2 days of strict bed rest in both healthy participants (71.4 ± 42.6 versus 84.1 ± 36.4 pmol/L) and those with type 2 diabetes (79.2 ± 50.3 versus 106.3 ± 46.6 pmol/L).

Three nonrandomized interventions reported significant increases in insulin levels ranging from 26 to 47% following uninterrupted sedentary behaviour \[[@B10], [@B23], [@B28]\] while 8 reported no change \[[@B21], [@B24]--[@B27], [@B29], [@B30]\]. The interventions that observed a change in insulin levels tended to impose uninterrupted sedentary behaviour for a longer period of time than those that found no change (6.0 ± 1.0 days versus 3.9 ± 2.6 days), although the mean number of participants (14.0 ± 7.0 versus 16.4 ± 13.3) and the quality of the studies did not appear to differ across the interventions. Effect sizes for these nonrandomized interventions ranged from −0.16 to 0.95, with all but one study reporting effect sizes in the small and moderate ranges.

Given the aforementioned evidence from both randomized and nonrandomized interventions, we conclude that an acute bout of uninterrupted sedentary behaviour may result in a small-to-moderate increase in fasting insulin levels. However, the inconsistency of this effect and the lack of a statistical significance in randomized interventions leads us to conclude that the quality of this evidence is very low ([Table 2](#tab2){ref-type="table"}).

3.3. Fasting Glucose {#sec3.3}
--------------------

Two randomized crossover studies (*n* = 22) \[[@B11], [@B22]\], one randomized controlled trial (*n* = 20) \[[@B33]\], and 14 nonrandomized intervention studies (*n* = 149) \[[@B10], [@B20], [@B23]--[@B30], [@B34]--[@B36]\] examined the impact of uninterrupted sedentary behaviour on fasting glucose levels. The one randomized controlled trial reported that, in comparison to ambulatory controls, plasma glucose levels were elevated by 34% following 7 days of uninterrupted bed rest \[[@B33]\]. The effect size in this randomized controlled trial was greater than 1, signifying a large effect. In contrast, neither randomized crossover study reported any change in fasting glucose levels following uninterrupted sedentary behaviour \[[@B11], [@B22]\]. One of these randomized crossover studies reported a moderate effect size of 0.43, \[[@B11]\], while the other reported small effect sizes of 0.07 and 0.14 in healthy participants and those with type 2 diabetes, respectively \[[@B22]\].

One nonrandomized intervention observed a significant increase in glucose levels of moderate size \[[@B10]\], one reported a significant reduction of moderate size \[[@B36]\], and one intervention observed moderate and large reductions in males and females, respectively, although this change was only significant in females \[[@B23]\]. The 11 other intervention studies did not observe any significant change in fasting glucose levels following uninterrupted sedentary behaviour \[[@B20], [@B24]--[@B30], [@B32], [@B34], [@B35]\]. The effect sizes among these 11 studies ranged from −1.21 to 0.47.

Given the evidence provided by 17 separate intervention studies, we conclude that an acute bout of uninterrupted sedentary behaviour may result in a small-to-moderate increase in fasting glucose levels. However, the high level of inconsistency from both randomized and nonrandomized interventions leads us to conclude that this evidence is of very low quality.

3.4. Fasting Triglycerides {#sec3.4}
--------------------------

One randomized controlled trial (*n* = 30) \[[@B37]\] and 3 nonrandomized interventions (*n* = 51) \[[@B10], [@B34], [@B38]\] assessed the impact of uninterrupted sedentary behaviour on fasting triglyceride levels ([Figure 3](#fig3){ref-type="fig"}). The randomized controlled trial \[[@B37]\] exposed 20 men to one week of bed rest and assessed triglyceride levels on days 1, 3, and 7. The 20 men in the experimental group were further split into two groups of 10---those who knew when their bed rest would begin (*acute* bed rest), and those who were not told when it would begin (*rigorous* bed rest). In comparison to the control group, triglyceride levels were significantly elevated by 30.2% in the acute group after one day, although no change was observed in the rigorous group. Following 3 days of bed rest, triglyceride levels were elevated by 15.2% and 23.6% in the acute and rigorous bed rest groups, respectively. At the completion of 1 week of bed rest, triglyceride levels remained elevated by 36.8% and 31.9% in the acute and rigorous bed rest groups in comparison to the control group. The effect size for sedentary behaviour in this intervention was above 1 for both intervention groups on days 1, 3, and 7, indicating a large effect.

The three nonrandomized interventions also found that acute sedentary behaviour resulted in significant increases in triglyceride levels \[[@B10], [@B34], [@B38]\]. Hamburg et al. \[[@B10]\] reported that triglyceride levels were elevated by 34.8% following 5 days of bed rest in 20 healthy men and women. Navasiolava et al. \[[@B34]\] observed that although no change in triglyceride levels was observed following 3 days of acute sedentary behaviour in a group of 8 male participants, triglyceride levels were 58.9% higher than baseline on day 7. Finally, Yanagibori et al. \[[@B38]\] found that triglyceride levels were elevated by 38.1% following 3 days of bed rest in men, but not women. With the exception of male participants in one study \[[@B38]\], the effect sizes reported in these nonrandomized interventions were all moderate to large.

Given the large and relatively consistent changes in triglyceride levels reported by both a randomized controlled trial and nonrandomized interventions, we conclude that acute bouts of uninterrupted sedentary behaviour result in a moderate-to-large increase in circulating triglyceride levels and that the available evidence is of moderate quality.

3.5. Fasting HDL-Cholesterol {#sec3.5}
----------------------------

Three nonrandomized interventions (*n* = 51) \[[@B10], [@B34], [@B38]\] reported on the effect of uninterrupted sedentary behaviour ranging from 3 to 7 days on HDL-cholesterol levels. Two interventions reported nonsignificant reductions in HDL-cholesterol levels following sedentary behaviour \[[@B10], [@B34]\] while one study \[[@B38]\] reported significant reductions of 11.5% and 19.3% in men and women, respectively, following 3 days of bed rest. The effect sizes in these studies ranged from 0.09 to 0.84, suggesting that acute bouts of uninterrupted sedentary behaviour may result in moderate reductions in HDL-cholesterol levels. However, given the inconsistency of these findings and the lack of data from randomized interventions, we conclude that the available evidence is of very low quality.

3.6. LDL-Cholesterol {#sec3.6}
--------------------

Two nonrandomized interventions (*n* = 28) \[[@B10], [@B34]\] examined the relationship between uninterrupted sedentary behaviour and changes in LDL-cholesterol levels following 3 \[[@B34]\], 5 \[[@B10]\], and 7 \[[@B34]\] days of sedentary behaviour. Although the studies reported moderate-sized increases in LDL-cholesterol levels at all time points, none of these increases were statistically significant. Thus, while the available evidence suggests that an acute bout of uninterrupted sedentary behaviour may result in a moderate increase in LDL-cholesterol levels, the quality of this evidence is very low.

3.7. Insulin Sensitivity {#sec3.7}
------------------------

Three randomized crossover studies (*n* = 41) \[[@B11], [@B22], [@B39]\] and 10 nonrandomized interventions (*n* = 120) \[[@B10], [@B19], [@B23], [@B24], [@B28], [@B29], [@B32], [@B38], [@B40], [@B41]\] examined the relationship between acute bouts of uninterrupted sedentary behaviour and measures of insulin sensitivity in healthy adults ([Figure 4](#fig4){ref-type="fig"}). The measures employed included HOMA \[[@B10], [@B32], [@B41]\], QUICKI \[[@B22]\], insulin-stimulated glucose uptake \[[@B11]\], insulin sensitivity index \[[@B10]\], insulin area under-the-curve (AUC) during oral glucose tolerance tests or standardized meals \[[@B23], [@B24], [@B28], [@B38], [@B39], [@B41]\], and hyperinsulinemic euglycemic clamps \[[@B19], [@B28], [@B40]\]. The crossover studies measured insulin sensitivity during 5 hours of sedentary behaviour \[[@B39]\], as well as before and after 1 \[[@B11], [@B22]\] and 2 \[[@B22]\] days of sedentary behaviour. The nonrandomized interventions assessed insulin sensitivity before and after 3 \[[@B24], [@B29], [@B38]\], 5 \[[@B10]\], 6 \[[@B23]\], and 7 \[[@B19], [@B28], [@B40], [@B41]\] days of sedentary behaviour.

Two of the three randomized crossover studies \[[@B11], [@B39]\] reported that uninterrupted sedentary behaviour had a deleterious effect on insulin sensitivity. Stephens et al. reported that insulin-stimulated glucose uptake was 39% lower following a day of acute sitting in a group of 12 healthy adults, in comparison to a day that minimized sitting \[[@B11]\]. Similarly, Dunstan et al. reported that the insulin AUC following a standardized meal was increased by 30% following 5 hours of uninterrupted sitting in a group of 19 overweight adults, in comparison to 5 hours of sitting which was broken up with periodic light-intensity walk breaks \[[@B39]\]. The third crossover study \[[@B22]\] reported that 1 day of sedentary behaviour resulted in a nonsignificant reduction in QUICKI scores in 5 healthy adults and a nonsignificant increase in 5 adults with type 2 diabetes. A significant reduction in insulin sensitivity was observed following two days of bed rest in participants with type 2 diabetes, but not in healthy adults. The significant reduction in participants with type 2 diabetes following 2 days of bed rest was of moderate size, while the nonsignificant reduction in healthy participants was small.

Eight of the 10 nonrandomized trials reported significant reductions in insulin sensitivity ranging from 12.5% to 100% following uninterrupted sedentary behaviour. For example, Hamburg et al. \[[@B10]\] reported that HOMA insulin sensitivity was reduced by 50% following 5 days of bed rest in 20 healthy adults, while the insulin sensitivity index was reduced by 12.5% in the same group of subjects. Similarly, Yanagibori et al. \[[@B38]\] report that insulin AUC during an oral glucose tolerance test was increased by 16.6% in 10 men and 74.9% in 7 women following 3 days of bed rest. The effect sizes from these nonrandomized interventions ranged from 0.34 to 3.3.

Although the majority of studies (9/12) examining insulin sensitivity had no control group, the effect sizes of the sedentary behaviour interventions were consistently moderate to large. The results were also consistent, with 10 of 12 published studies reporting a reduction in insulin sensitivity in at least one subgroup of participants. Thus, we conclude that acute bouts of uninterrupted sedentary behaviour are likely to result in a moderate-to-large reduction in insulin sensitivity and that the available evidence is of moderate quality.

3.8. Glucose Tolerance Tests {#sec3.8}
----------------------------

Two randomized crossover studies (*n* = 32) \[[@B39], [@B42]\] examined the impact of 2 \[[@B42]\] and 5 hours \[[@B39]\] of prolonged sitting on glucose AUC in response to a standard meal, while seven nonrandomized interventions (*n* = 87) \[[@B23], [@B24], [@B27]--[@B29], [@B38], [@B41]\] examined the impact of uninterrupted sedentary behaviour lasting 3 \[[@B24], [@B38]\], 6 \[[@B23]\], and 7 \[[@B27], [@B28], [@B41]\] days on measures of glucose tolerance.

Both of the randomized crossover studies reported that uninterrupted sitting resulted in significant increases in glucose AUC in response to a standardized meal. Nygaard et al. reported that 2 hours of sitting resulted in a 45% increase in the glucose response to a standard meal in a group of 13 elderly women, in comparison to a combination of sitting and walking at a self-selected "very light" intensity \[[@B42]\]. Similarly, Dunstan et al. reported that the glucose AUC following a test meal was 33% higher following 5 hours of prolonged sitting, in comparison to 5 hours of sitting which was broken up with periodic light-intensity walk breaks \[[@B39]\].

Five of seven nonrandomized studies reported significant reductions in glucose tolerance in at least some participants, ranging from 7.8 to 30%. For example, Smorawiński et al. \[[@B24]\] reported that glucose AUC during oral glucose tolerance tests was 30% higher following three days of bed rest in inactive young men, although there were no change in endurance- or strength-trained athletes. Yanagibori et al. \[[@B38]\] observed significant 7.8% reductions in oral glucose tolerance in women, but not men, following 3 days of bed rest. The effect sizes in these studies ranged from −0.03 to 1.4 and were in the moderate or high range for all but one study.

The available evidence suggests that acute bouts of uninterrupted sedentary behaviour may result in moderate-to-large reductions in oral glucose tolerance. Given the relatively consistent findings and the strong evidence from randomized crossover studies, we conclude that the evidence linking acute sedentary behaviour with reductions in glucose tolerance is of moderate quality.

3.9. Quality Assessment {#sec3.9}
-----------------------

Downs and Black scores assessing the risk of bias for individual studies are presented in [Table 1](#tab1){ref-type="table"}. The average score was 21.4 ± 2.3, out of a maximum of 32. The three randomized crossover studies had the highest quality (25.0 ± 1.7), followed by the randomized controlled trials (22.5 ± 2.1) and the nonrandomized interventions (20.8 ± 1.9). The overall quality of evidence related to each outcome is presented in [Table 2](#tab2){ref-type="table"}.

4. Discussion {#sec4}
=============

Based on our systematic review of data from 25 independent interventions, we found moderate quality evidence suggesting that acute bouts of uninterrupted sedentary behaviour lasting 2 hours to 7 days result in rapid and deleterious changes in triglyceride levels, insulin sensitivity, and glucose tolerance. We also found very low-quality evidence that it results in changes in fasting glucose, fasting insulin, and HDL- or LDL-cholesterol.

The findings of the current paper have important public health implications. Recent estimates suggest that on average North American adults and children spend 7--10 hours per day---more than half their waking hours---engaging in sedentary behaviour \[[@B43]--[@B46]\]. This suggests that many individuals likely spend several consecutive hours sitting down on a regular basis, which is not dissimilar to the protocol employed by 3 randomized crossover studies in this paper that resulted in significant reductions in insulin sensitivity and glucose tolerance \[[@B11], [@B39], [@B42]\]. Individuals who perform long bouts of uninterrupted sedentary behaviour on a regular basis may therefore be exposing themselves to higher levels of circulating triglycerides, as well as reduced insulin sensitivity and glucose tolerance, which may help to explain the prospective associations between sedentary behaviour and chronic disease morbidity and mortality \[[@B3]--[@B5]\].

Research in animal models suggests mechanisms that may explain our observation of consistent changes in both insulin sensitivity and plasma triglyceride levels in response to uninterrupted sedentary behaviour. Bey and Hamilton reported that just 18 hours of hindlimb unloading results in near total cessation of lipoprotein lipase activity and roughly 75% reduction in triglyceride uptake in rat skeletal muscle \[[@B12]\]. Similarly, it is also well established that skeletal muscle denervation results in rapid changes in glucose transport protein expression and reductions in insulin sensitivity \[[@B13], [@B14]\]. These findings suggest that rapid and deleterious changes in skeletal muscle metabolic function may underlie the relationship between sedentary behaviour, triglyceride levels, and insulin sensitivity observed in the present review.

4.1. Strengths and Limitations {#sec4.1}
------------------------------

The major strength of this paper is its rigorous systematic methodology. The search strategy was developed in consultation with a research librarian with expertise in search creation, and the screening process included two independent reviewers who came to consensus on all included studies. Strength of evidence was assessed using GRADE in order to increase the transparency of the grading process. Finally, the paper was prospectively registered with PROSPERO.

The limitations of this paper relate primarily to the quality of evidence that is presently available. Of 25 independent interventions identified by this paper, only 6 employed a randomized design. Further, although fasting glucose, glucose tolerance, insulin, and insulin sensitivity have each been examined by 9 or more investigations, lipid levels have received little attention by comparison. Given the small number of studies and the low quality of evidence currently available for these outcomes, it is difficult to determine their relationship with sedentary behaviour with any certainty.

There has also been a large amount of heterogeneity in the modality of sedentary behaviour (e.g., sitting versus bed rest) and in the way that outcome measures are calculated, which precluded the use of meta-analyses in the present paper. Only 5 studies identified by the current paper examined a modality of sedentary behaviour other than bed rest. The modality of sedentary behaviour which is most common in daily life is undoubtedly sitting, yet the acute impact of sitting has only been examined in four interventions. In contrast the metabolic impact of bed rest has received far more attention in the published literature \[[@B16]\], despite the fact that prolonged periods of bed rest are uncommon in day-to-day life. Given that it is unclear whether sitting and bed rest have a similar impact on markers of cardiometabolic risk, it is important that future studies focus on the impact of sitting to determine whether it has an impact which is similar to that of bed rest.

The sample size of most interventions identified by this paper was quite small, and the vast majority of studies were performed in physically fit, healthy young adult males between the ages of 20 and 30. We only identified two interventions focused on individuals above the age of 50 \[[@B39], [@B42]\], or those with elevated body weight \[[@B22], [@B39]\] and we were not able to identify any interventions focusing on pediatric populations. Further, females made up just 16% of the participants in the identified interventions, which makes it unclear whether the relationships observed in the current paper will generalize to females of any age.

It is also worth noting that, at present, it is difficult to differentiate the impact of sedentary behaviour *per se* from that of a positive energy balance. If energy intake is maintained at an individual\'s habitual level, it can be assumed that an imposed bout of sedentary behaviour is likely to result in positive energy balance. However, to our knowledge only one intervention \[[@B11]\] has attempted to separate the impact of an acute bout of sedentary behaviour from that of acute positive energy balance. Interestingly, Stephens et al. report that reducing energy intake to match energy expenditure during a bout of prolonged sedentary behaviour reduced the deleterious impact on insulin sensitivity by roughly 50% \[[@B11]\]. Further, no studies identified in the current paper reported adjusting results for baseline physical activity, fitness, or diet. Future work should investigate these issues further, in order to determine the relative contributions of sedentary behaviour and positive energy balance to changes in cardiometabolic risk factors.

To date only three studies have examined the impact of uninterrupted sedentary behaviour lasting less than 1 day on markers of metabolic risk. Given that healthy individuals rarely spend 24 hours engaging in uninterrupted sedentary behaviour, it is important that future studies investigate whether shorter bouts of sedentary behaviour also have a measurable impact on metabolic health. Future work should also investigate the acute impact of sedentary behaviour on nontraditional markers of cardiometabolic risk including adipokines and markers of inflammation. Finally, none of the studies identified in the current paper examined whether these deleterious changes in risk markers persisted once participants returned to free living conditions. Thus, it is unclear whether the changes observed in the reviewed studies endure for several days following the cessation of sedentary behaviour, or whether they are rapidly resolved. Assessing the clinical significance of these changes will be difficult until their time-course has been more carefully examined.

5. Conclusions {#sec5}
==============

This study demonstrates that, at present, there is moderate quality evidence that acute bouts of uninterrupted sedentary behaviour result in significant and deleterious changes in insulin sensitivity, glucose tolerance, and plasma triglyceride levels. There is currently very low-quality evidence linking uninterrupted sedentary behaviour with changes in circulating insulin, glucose, and HDL- and LDL-cholesterol levels. There is no evidence that acute bouts of uninterrupted sedentary behaviour provide any positive changes in markers of cardiometabolic risk. However, the majority of studies identified by this paper focused on healthy young men, and it is therefore unclear whether these results will generalize to females or to other age groups. These findings suggest that uninterrupted bouts of sedentary behaviour should be avoided in order to prevent transient increases in metabolic risk.
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###### 

Characteristics of included studies.

  Reference                    Design   First author   Year   Country     *n* (M/F)    Age range   Mean age   Modality    Duration   Outcomes               Downs and Black
  ---------------------------- -------- -------------- ------ ----------- ------------ ----------- ---------- ----------- ---------- ---------------------- -----------------
  \[[@B37]\]                   RCT      Yaroshenko     1998   Greece      30 (30/0)    22--26      24.8       BR          7 days     TG                     24
  \[[@B33]\]                   RCT      Zorbas         1999   Bulgaria    30 (30/0)    22--26      24.3       BR          7 days     FG                     24
  \[[@B22]\]                   RCO      Duran-Valdez   2008   USA         10 (2/8)     24--72      46.2       BR          2 days     FI, FG, IS             21
  \[[@B11]\]                   RCO      Stephens       2010   USA         12 (6/6)     19--32      26.1       SIT         1 day      FI, FG, IS             24
  \[[@B39]\]                   RCO      Dunstan        2012   Australia   19 (11/8)    45--65      53.8       SIT         5 hours    IS, GT                 27
  \[[@B42]\]                   RCO      Nygaard        2009   Norway      13 (0/13)    \>50                   SIT         2 hours    GT                     23
  \[[@B21]\]                   NT       Alibegovic     2010   Denmark     38 (38/0)                25.0       BR          7 days     FI                     23
  \[[@B31]\]                   NT       Alibegovic     2009   Denmark     33 (33/0)                25.6       BR          7 days     FI                     23
  \[[@B23], [@B47]\]           NT       Blanc          2000   France      16 (8/8)                 30.2       HDBR        6 days     FI, FG, IS, GT         23
  \[[@B35]\]                   NT       Dolkas         1977   USA         7 (7/0)      19--22      20.0       BR          4 days     FG                     21
  \[[@B25]\]                   NT       Barbe          1999   France      8 (8/0)      23--31      27.1       HDBR        5 days     FI, FG                 21
  \[[@B10]\]                   NT       Hamburg        2007   USA         20 (14/6)                30.7       BR          5 days     FI, FG, IS, TG         23
  \[[@B20]\]                   NT       Katkov         1979   Russia      5 (5/0)                  34.0       BR          5 days     FG                     17
  \[[@B41]\]                   NT       Kiilerich      2011   Denmark     6 (6/0)      22--36      28.7       BR          7 days     IS, GT                 
  \[[@B36]\]                   NT       Ksinantova     2002   Slovakia    15 (15/0)                34.0       HDBR        4 days     FG                     20
  \[[@B29]\]                   NT       Lipman         1972   USA         7 (7/0)      18--20                 BR          3 days     FI, IS, GT             18
  \[[@B32]\]                   NT       Kanikowska     2010   Japan       8 (8/0)                  27.0       HDBR        5 days     FI, FG, IS             
  \[[@B27], [@B40]\]           NT       Mikines        1989   Denmark     6 (6/0)                  25.0       BR          7 days     FI, FG, IS, GT         20
  \[[@B30]\]                   NT       Moro           2007   France      8 (8/0)      22--27      23.0       HDBR, SIT   4 hours    FI, FG                 20
  \[[@B34]\]                   NT       Navasiolava    2010   Russia      8 (8/0)                  23.0       BR          7 days     FG, TG, HDL, LDL       22
  \[[@B26]\]                   NT       Nygren         1997   Sweden      6 (6/0)                  24.1       BR          1 day      FI, FG, IS             22
  \[[@B19]\]                   NT       Richter        1989   Denmark     5 (5/0)      22--24                 CAST        7 days     IS                     20
  \[[@B24], [@B48], [@B49]\]   NT       Smorawinski    1996   Poland      29 (29/0)                20.10      BR          3 days     IS, GT                 19
  \[[@B28]\]                   NT       Stuart         1988   USA         6 (6/0)      21--28      23.0       BR          7 days     FI, FG, IS, GT         22
  \[[@B38]\]                   NT       Yanagibori     1997   Japan       23 (13/10)   19--25                 BR          3 days     IS, GT, TG, HDL, LDL   22

RCT: randomized controlled trial; RCO: randomized crossover; NT: nonrandomized trial; M: male; F: female; HDBR: head-down bed rest; 22BR: horizontal or head-up bed rest; SIT: sitting; CAST: casting; FG: fasting glucose; FI: fasting insulin; TG: triglycerides; HDL: HDL-cholesterol; LDL: LDL-cholesterol; IS: insulin sensitivity; GT: glucose tolerance.

When an intervention was described in more than one paper, the author name and year are taken from the earliest publication.

###### 

Summary of key evidence.

  Risk factor           Number of studies   Number of participants (M/F)   Size of effect      Quality of evidence
  --------------------- ------------------- ------------------------------ ------------------- ---------------------
  Insulin sensitivity   11                  161 (118/43)                   Moderate-to-Large   Moderate quality
  Triglycerides         4                   81 (65/16)                     Moderate-to-Large   Moderate quality
  Glucose tolerance     6                   119 (83/36)                    Moderate-to-Large   Moderate quality
  HDL-cholesterol       3                   51 (35/16)                     Moderate            Very low quality
  Fasting insulin       14                  207 (187/20)                   Small-to-Moderate   Very low quality
  Fasting glucose       17                  191 (163/28)                   Small-to-Moderate   Very low quality
  LDL-cholesterol       2                   28 (22/6)                      Moderate            Very low quality

[^1]: Academic Editor: Maria Luz Fernandez
